logo

FDA Calendar

Share
Company Name RHYTHM PHARMACEUTICALS, INC.
Drug Name Setmelanotide (NDA)
Event Name FDA decision on Setmelanotide for pro-opiomelanocortin deficiency obesity and leptin receptor deficiency obesity
Event Date 11/27/2020
Outcome Date
Outcome
Drug Status Priority review
Rival Drugs
Market Potential
Other Approvals
News
Return to FDA Calendar